The company also reported a total cash flow provided by operations of $1.8 billion for the second quarter, driven by improved pharmacy rebate remittance timing. Management's Perspective Sarah M. London, Chief Executive Officer of Centene, expressed disappointment with the second quarter results but emphasized the company's understanding of the trends impacting performance. She highlighted the strong staying power of Medicaid, Medicare, and the Individual Marketplace, and reiterated Centene's commitment to adapting to market changes to deliver value to members, stakeholders, and shareholders. Future Outlook Centene Corporation will provide its 2025 earnings expectations during a conference call scheduled for July 25, 2025. Investors and interested parties can access the call via the company's website or through a live audio webcast. SEC Filing: CENTENE CORP [ CNC ] - 8-K - Jul. 24, 2025